Rituximab, dexamethasone, cytarabine, and oxaliplatin (R-DHAX) is an effective and safe salvage regimen in relapsed/refractory B-cell non-Hodgkin lymphoma
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Nicolas Mounier Catherine Thieblemont |
| Publication date | August 1, 2010 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |